Degenerative Disc Disease Treatment Market Analysis

Degenerative Disc Disease Treatment Market Analysis

The treatment of degenerative disc disease (DDD) involves surgical interventions that often come with a high cost. Procedures such as discectomy, spinal fusion, artificial disc replacement are expensive, impacting access for patients with limited financial resources and inadequate insurance coverage. Thus, high cost of surgical interventions may act as a barrier, hindering patients from pursuing these treatment options and potentially limiting the growth of the DDD treatment industry. Also, post-surgical complications such as bleeding, nerve damage and inflammation may possibly impede the market share.

To get key market trends

  Download Free Sample

By product type, the degenerative disc disease treatment market is classified into drugs and devices. The devices segment accounted over 51% of the market share in 2022 and is projected to witness robust growth over the analysis timeframe. Degenerative disc disease (DDD) treatment involves the use of specialized devices in different areas of the spine that offers various benefits for managing DDD effectively. Cervical spine devices such as artificial discs provide stability, restore disc height and maintain proper alignment by reducing pain and improving functionality in the neck. Lumbar spine devices, such as interbody cages, pedicle screws address instability and nerve compression and offer support and restoring stability in the lower back.

Based on end-use, the degenerative disc disease treatment market is segmented into hospitals, clinics and others. The hospitals are expected to register USD 26.6 billion in 2032. Hospitals include specialized departments with skilled surgeons and advanced diagnostic technologies. Multidisciplinary care teams ensure personalized treatment plans and coordinated care for degenerative disc treatment that enables to attain improved patient outcomes. Furthermore, growing technological advancements in degenerative disc disease treatment and increase in hospital admissions for surgeries and treatments will further stimulate the market expansion.

North America degenerative disc disease treatment market accounted for over 57% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. Increasing prevalence of DDD, coupled with advancements in medical technology and growing geriatric population has significantly fueled the market size in the North America region. Furthermore, presence of key market players and favorable government regulation for novel drugs and devices development is expected to proliferate the regional market outlook.